$20.89
+1.09 (+5.51%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+4.24%
1Y
+105.61%
YTD
+12.92%
Open$20.19
Previous Close$19.80
Day High$21.00
Day Low$20.11
52W High$25.00
52W Low$8.06
Volume—
Avg Volume2.12M
Market Cap3.27B
P/E Ratio—
EPS$-3.22
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$18.16
Above
SMA 200
$14.91
Above
RSI (14)
28.7
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+368.5% upside
Current
$20.89
$20.89
Target
$97.86
$97.86
$76.65
$97.86 avg
$132.93
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 618.44M | 584.19M | 668.57M |
| Net Income | 86.92M | 95.40M | 98.23M |
| Profit Margin | 14.1% | 16.3% | 14.7% |
| EBITDA | 124.54M | 120.89M | 157.55M |
| Free Cash Flow | 66.24M | 92.85M | 89.99M |
| Rev Growth | +16.5% | -3.4% | +9.6% |
| Debt/Equity | 0.27 | 0.23 | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |